Treatment of experimentally induced osteoarthritis in horses using an intravenous combination of sodium pentosan polysulfate, N-acetyl glucosamine, and sodium hyaluronan.
Authors: Koenig Toby J, Dart Andrew J, McIlwraith C Wayne, Horadagoda Neil, Bell Robin J, Perkins Nigel, Dart Christina, Krockenberger Mark, Jeffcott Leo B, Little Christopher B
Journal: Veterinary surgery : VS
Summary
# Editorial Summary Researchers induced osteoarthritis in the intercarpal joint of 16 Standardbred horses and treated half with weekly intravenous infusions of a combination therapy containing pentosan polysulfate (3 mg/kg), N-acetyl glucosamine (4.8 mg/kg), and sodium hyaluronate (0.12 mg/kg), whilst the remainder received saline controls over 10 weeks of standardised exercise. The treatment group demonstrated statistically significant improvements in gross pathology scores and total radiographic changes compared to controls; however, these encouraging macroscopic findings were not mirrored in histological cartilage assessment, synovial fluid biomarkers of cartilage degradation, or clinical lameness parameters—in fact, treated horses showed elevated synovial white blood cell counts and protein concentrations, suggesting a possible inflammatory response. Whilst the reduction in visible joint damage is noteworthy, the disconnect between macroscopic improvements and the absence of supporting evidence at the cellular and molecular level raises questions about the clinical relevance of these findings. The authors appropriately conclude that this combination therapy cannot yet be recommended as a proven treatment option, and equine practitioners should await further evidence before incorporating this protocol into management strategies for osteoarthritis cases.
Read the full abstract on PubMed
Practical Takeaways
- •Despite some macroscopic cartilage improvements, this intravenous combination therapy did not demonstrate consistent clinical benefit across multiple outcome measures and requires further investigation before routine use in OA cases
- •The lack of improvement in synovial fluid biomarkers and histologic cartilage scores suggests the treatment may not be modifying the underlying disease process as effectively as hoped
- •Current evidence is insufficient to recommend this specific intravenous combination protocol for managing naturally occurring osteoarthritis in clinical practice
Key Findings
- •PGH treatment significantly reduced total radiographic scores, macroscopic joint pathology, and macroscopic cartilage pathology compared to saline controls
- •OA induction successfully increased clinical assessment scores, synovial fluid variables, and cartilage damage markers in both treatment groups
- •Synovial fluid protein and white blood cell counts were higher in PGH-treated OA joints compared to saline controls, suggesting ongoing inflammation
- •Macroscopic improvements with PGH were not supported by histologic, biochemical, or clinical outcome measures